Evotec, Odyssey Therapeutics Team Up on Autoimmune, Inflammatory Disease Treatment Research

MT Newswires · 2d ago
03:21 AM EDT, 08/06/2026 (MT Newswires) -- Evotec (EVT.F) is collaborating with clinical-stage biopharmaceutical company Odyssey Therapeutics on a research initiative for new autoimmune and inflammatory disease treatments. The companies are looking to discover and validate differentiated small-molecule drug candidates for a variety of disease targets through the partnership, according to a Thursday filing. The German life science company will be entitled to milestone payments for each successful delivery of a validated hit series for each disease target.